Molecular Partners AG is a clinical-stage biopharmaceutical company based in Schlieren, Switzerland, specializing in the development of DARPin therapeutics. DARPins, or Designed Ankyrin Repeat Protein... Molecular Partners AG is a clinical-stage biopharmaceutical company based in Schlieren, Switzerland, specializing in the development of DARPin therapeutics. DARPins, or Designed Ankyrin Repeat Proteins, represent a novel class of custom-built protein drugs derived from natural binding proteins, offering high specificity, multi-functionality, and multi-target capabilities that surpass limitations of conventional modalities like monoclonal antibodies. The company focuses primarily on oncology, immuno-oncology, ophthalmology, and infectious diseases, with candidates in clinical and preclinical stages, including radio-DARPins, tetra-specific T cell engagers, and switch-DARPins targeting markers such as DLL3, CD33, CD123, CD70, and mesothelin. Molecular Partners AG has established strategic partnerships with major pharmaceutical firms including Allergan, Amgen, Roche, Janssen, and Novartis, fostering co-development of innovative therapies. Employing around 153 professionals, it advances a pipeline addressing unmet medical needs in cancer and serious disorders through its proprietary platform.
Disclosures of Molecular Partners
Explore Molecular Partners's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Molecular Partners's official channels and fully traceable to its official company sources.
The table below lists all of Molecular Partners's' corporate disclosure by name and reporting period, ensuring full transparency and easy access.
Fiscal Year / Type
Languages
20252 disclosures
Annual Report
en
20-F
en
Real-Time Disclosures Datafeed
Get Notified Within Seconds of New Corporate Disclosures
Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?
Account Restricted
Your account has been restricted and you no longer have access to paid features.
Contact our support team orupgrade your planto unblock your account.